Applications designed to successfully implant in challenging left atrial appendage occlusion cases: a new tool for

José Ramón López-Mínguez1, Ginés Martínez-Cáceres2, Reyes González-Fernández2

  • 1Interventional Cardiology Section, Cardiology Service, University Hospital of Badajoz, Avda Elvas sn Badajoz, 06080, Badajoz, Spain. lopez-minguez@hotmail.com.

Insights

This case study highlights left atrial appendage occlusion (LAAO) for an elderly patient with atrial fibrillation experiencing recurrent gastrointestinal bleeding despite anticoagulation. LAAO offers a potential solution for stroke risk reduction in high-risk patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Permanent atrial fibrillation necessitates anticoagulation to prevent stroke.
  • Recurrent gastrointestinal bleeding poses a significant risk, complicating anticoagulation management.
  • High stroke risk scores (CHA2DS2-VASc=4) and bleeding risk scores (HAS-BLED=3) indicate a complex clinical scenario.

Observation:

  • An 85-year-old patient with permanent atrial fibrillation and a DDD pacemaker presented with recurrent gastrointestinal bleedings.
  • Anticoagulation with apixaban was insufficient to prevent bleeding events.
  • The patient was deemed a candidate for left atrial appendage occlusion (LAAO).

Findings:

  • Left atrial appendage occlusion (LAAO) was performed as a therapeutic intervention.
  • This procedure aims to mitigate stroke risk in patients with atrial fibrillation.
  • LAAO provides an alternative to long-term anticoagulation in specific high-risk patient profiles.

Implications:

  • LAAO may be a viable option for patients with atrial fibrillation and high bleeding risk, refractory to anticoagulation.
  • This approach could reduce the incidence of both thromboembolic events and major bleeding.
  • Further research into LAAO outcomes in complex elderly populations is warranted.